Takayasu K, Muguruma K, Kinoshita H. Durable complete response to combination nivolumab and ipilimumab in metastatic renal cell carcinoma. Trends Immunother. [Internet]. 2022 Jan. 14 [cited 2025 Sep. 4];6(1). Available from: http://ojs.ukscip.com/index.php/ti/article/view/426